Argonne maintains a wide-ranging science and technology portfolio that seeks to address complex challenges in interdisciplinary and innovative ways. Below is a list of all articles, highlights, profiles, projects, and organizations related specifically to structural biology.
Researchers have developed antibodies that can bind to phosphohistidine, an unstable molecule that’s linked to cancer. To learn how the two bind together, the team turned to the powerful X-rays at Argonne’s Advanced Photon Source.
Clinical trials have begun on a new vaccine candidate that may protect against variants of the SARS-CoV-2 virus. Protein structures determined at the Advanced Photon Source helped to guide the development of this vaccine.